| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Amit Indubhushan Bakshi CEO | XNSE Exchange | INE406M01024 ISIN |
| India Country | 3,620 Employees | 29 May 2026 Last Dividend | - Last Split | - IPO Date |
Eris Lifesciences Limited is an India-based company that operates within the healthcare sector, focusing primarily on the development, manufacture, marketing, and distribution of branded formulations. The company has tailored its product offerings to address chronic and sub-chronic therapies, serving a wide range of therapeutic areas. Established in 2007 and headquartered in Ahmedabad, India, Eris Lifesciences has grown to become a key player in the Indian pharmaceutical market. Through its extensive network of wholesale drug distributors, stockiest, and retail pharmacies, the company ensures wide accessibility to its products across the country. Additionally, Eris Lifesciences is committed to enhancing patient care by providing a range of patient care services that complement its product offerings.
The comprehensive product portfolio of Eris Lifesciences spans across multiple therapeutic areas, crafted to meet the diverse needs of the healthcare industry and patient population in India. Here is an overview of their key products and services:
Alongside its extensive product range, Eris Lifesciences offers a suite of patient care services aimed at improving the quality of healthcare delivery. These services include: